Measuring five quality-base performance areas, an ambulatory surgical center out performed a standard hospital based surgical center in otolaryngic surgeries, according to new research in the December 2009 issue of Otolaryngology – Head and Neck Surgery.

Pharmasset, Inc. (Nasdaq: VRUS) announced that the enrollment of Cohort 2, led by its partner Roche (SWX: ROG.VX; RO.S, OTCQX: RHHBY), will continue for the remaining 300 genotype 1 and 4 patients in the ongoing phase 2b trial of RG7128, a first-in-class nucleoside analog polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) [...]

Bristol-Myers Squibb Company (NYSE: BMY) announced results of two ORENCIA® (abatacept) studies at the 2009 Annual European Congress of Rheumatology (EULAR) currently being held in Copenhagen, Denmark.

The 2009 HealthGrades Patient Safety Excellence Award™ recipients were identified in a report issued by the leading independent healthcare ratings organization. These hospitals represent an elite group that save lives, save money and prevent errors at a higher rate than other U.S. hospitals.

Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced positive topline results from Study 304, a Phase III clinical trial of Acetavance(TM), the company’s intravenous formulation of acetaminophen, for the treatment of acute pain following abdominal laparoscopic surgery. Study 304 successfully met its primary endpoint of a statistically significant reduction in summed pain intensity differences from baseline over [...]